(VIANEWS) – Shares of TherapeuticsMD (NASDAQ: TXMD) dropped by a staggering 11.31% to $2.79 at 10:26 EST on Tuesday, after five consecutive sessions in a row of gains. NASDAQ is rising 1.71% to $11,861.99, following the last session’s downward trend. This seems, at the moment, an all-around positive trend trading session today.

TherapeuticsMD’s last close was $3.14, 14.18% above its 52-week high of $2.75.


Today’s last reported volume for TherapeuticsMD is 190432 which is 26.62% below its average volume of 259546.

TherapeuticsMD’s Sales

TherapeuticsMD’s sales growth is 33.7% for the present quarter and 29.3% for the next. The company’s growth estimates for the current quarter and the next is 16.7% and 40%, respectively.

TherapeuticsMD’s Revenue

Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.


TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 13.58%, a negative 5.84%, and a positive 7.15%, respectively.

TherapeuticsMD’s highest amplitude of average volatility was 15.85% (last week), 6.99% (last month), and 7.15% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

TherapeuticsMD’s stock is considered to be overbought (>=80).

TherapeuticsMD’s Stock Yearly Top and Bottom Value

TherapeuticsMD’s stock is valued at $2.79 at 10:26 EST, above its 52-week high of $2.75.

TherapeuticsMD’s Moving Average

TherapeuticsMD’s worth is way above its 50-day moving average of $0.66 and way higher than its 200-day moving average of $1.00.

More news about TherapeuticsMD (TXMD).


Please enter your comment!
Please enter your name here